By Sheri Kasprzak
New York, Aug. 9 - Norwood Abbey Ltd. wrapped a private placement for A$4 million.
The company sold 10.1 million shares of Norwood Immunology Ltd. The exact price per share could not be determined Wednesday.
Based in Melbourne, Australia, Norwood Abbey develops products used in laser eye surgery and other optical procedures.
Issuer: | Norwood Abbey Ltd.
|
Issue: | Stock
|
Amount: | A$4 million
|
Shares: | 10.1 million
|
Warrants: | No
|
Settlement date: | Aug. 9
|
Stock symbol: | Australia: NAL
|
Stock price: | A$0.175 at close Aug. 9
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.